Sign in

CIK 0001840233

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Xilio Therapeutics, Inc.

Sign in to watch
Ticker
XLO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
851623397
Phone
+1 617-833-1027
Business address
828 WINTER STREET, WALTHAM, MA, 02451
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2021-10-26 BAY CITY CAPITAL LLC 10% owner Conversion +665,696 665,696
2021-10-26 BAY CITY CAPITAL LLC 10% owner Conversion +151,294 816,990
2021-10-26 BAY CITY CAPITAL LLC 10% owner Purchase +312,500 $16.00 $5.0M 1,129,490
2021-10-26 BAY CITY CAPITAL LLC 10% owner Conversion · Series B Preferred Stock −6,324,110 0
2021-10-26 BAY CITY CAPITAL LLC 10% owner Conversion · Series C Preferred Stock −1,437,297 0

Page 1 of 1 · 5 trades